Commission Implementing Decision (EU) 2021/2149 of 3 December 2021 on unresolved objections regarding the terms and conditions of the provisional authorisation of a biocidal product containing 5-Chloro-2-methyl-2H-isothiazol-3-one (C(M)IT) referred by France in accordance with Article 36(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021)8693) (Text with EEA relevance)

• CELEX: Implementing Decision (EU) 2021/2149
• Articles: 3

Article 1

This Decision applies to the biocidal product identified by the case number BC-DW041712-25 in the Register for Biocidal Products.

Article 2

The biocidal product referred to in Article 1 of this Decision is expected to meet the conditions laid down in Article 19(1), points (b)(iii) and (b)(iv), of Regulation (EU) No 528/2012, provided that the provisional authorisations granted by Member States stipulate both of the following conditions:

(a)

for use 2 (in-can preservation of paints and coatings) and use 7 (preservation of polymer dispersions), as described in the application for the mutual recognition, articles treated with the biocidal product can only be used indoors;

(b)

the person responsible for the placing on the market of such treated articles ensure that the label of such treated articles provides the following instruction ‘Indoor use only’.

Article 3

This Decision is addressed to the Member States.